Breaking News

AVM and MBC Biolabs Announce the Winners of the ‘Future Innovator Prize’

Vcreate & Weatherwax Biotechnologies receive one-year usage of MBC BioLabs' lab facility, as well as access to Astellas' R&D capabilities & business leaders.

Author Image

By: Charlie Sternberg

Associate Editor

Astellas Venture Management LLC (AVM), a wholly-owned venture capital subsidiary of Astellas Pharma Inc., and Mission Bay Capital BioLabs (MBC BioLabs), a life-science incubator, have announced Vcreate and Weatherwax Biotechnologies as the winners of the Astellas-sponsored “Future Innovator Prize” at MBC BioLabs.   A Future Innovator Prize offers entrepreneurial scientists or emerging biotechnology startups one-year usage of MBC BioLabs’ lab facility in San Francisco, Californi...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters